Claudio D'Amore Selected Research

Claudio D'Amore Research Topics

Disease

8	Inflammation (Inflammations) 01/2014 - 01/2011
7	Neoplasms (Cancer) 01/2023 - 01/2013
5	Cystic Fibrosis (Mucoviscidosis) 02/2024 - 01/2021
5	Colitis 11/2013 - 01/2011
4	Cholestasis 01/2015 - 01/2012
3	Stomach Neoplasms (Stomach Cancer) 01/2016 - 01/2013
3	Dyslipidemias (Dyslipidemia) 02/2014 - 01/2012
3	Atherosclerosis 05/2013 - 01/2012
2	Infections 01/2014 - 10/2012
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2013 - 07/2011
1	Inborn Genetic Diseases (Disease, Hereditary) 02/2024
1	COVID-19 01/2021
1	Bipolar Disorder (Manic Depressive Psychosis) 10/2019
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 10/2019
1	Schizophrenia (Dementia Praecox) 10/2019
1	Mental Disorders (Mental Disorder) 10/2019
1	Autoimmune Diseases (Autoimmune Disease) 12/2016
1	Adenocarcinoma 01/2016
1	Pruritus (Itching) 01/2015
1	Obesity 02/2014
1	Rheumatoid Arthritis 12/2013
1	Arthritis (Polyarthritis) 12/2013
1	Peritoneal Diseases 12/2013
1	HIV Infections (HIV Infection) 05/2013
1	Coronary Disease (Coronary Heart Disease) 05/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2013
1	Carcinoma (Carcinomatosis) 01/2013
1	Peritoneal Neoplasms 01/2013
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2012
1	Necrosis 01/2012
1	Liver Diseases (Liver Disease) 01/2012
1	Insulin Resistance 01/2012
1	Fatty Liver 01/2012
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2012

Drug/Important Bio-Agent (IBA)

6	LigandsIBA 01/2015 - 11/2011
5	Bile Acids and Salts (Bile Acids)IBA 01/2016 - 01/2012
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2016
3	Cadherins (E-Cadherin)IBA 01/2016 - 01/2013
3	Ritonavir (Norvir)FDA Link 01/2014 - 01/2012
3	Protease Inhibitors (Protease Inhibitor)IBA 01/2014 - 01/2012
3	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 10/2012 - 01/2011
2	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 02/2024 - 08/2022
2	AnionsIBA 02/2024 - 08/2022
2	Protein Kinases (Protein Kinase)IBA 01/2023 - 03/2021
2	silmitasertibIBA 03/2021 - 12/2020
2	Casein Kinase II (Casein Kinase 2)IBA 03/2021 - 12/2020
2	Phosphotransferases (Kinase)IBA 12/2020 - 11/2020
2	Messenger RNA (mRNA)IBA 01/2016 - 01/2014
2	cholan-2,3,24-tryl-2,3,24-trisulfateIBA 12/2013 - 07/2011
2	CytokinesIBA 12/2013 - 07/2011
2	Chemokine CCL5IBA 12/2013 - 12/2013
2	Maraviroc FDA Link 12/2013 - 05/2013
2	Apolipoproteins E (ApoE)IBA 05/2013 - 01/2012
2	LipidsIBA 10/2012 - 01/2012
1	ChloridesIBA 08/2022
1	tezacaftorIBA 03/2022
1	elexacaftorIBA 03/2022
1	tezacaftor drug combination ivacaftor elexacaftorIBA 03/2022
1	ivacaftorIBA 03/2022
1	5- (3- ethynylphenylamino)pyrimido(4,5- c)quinoline- 8- carboxylic acidIBA 11/2020
1	Amphetamine (Amfetamine)FDA LinkGeneric 10/2019
1	Dopamine (Intropin)FDA LinkGeneric 10/2019
1	Immunomodulating AgentsIBA 12/2016
1	BAR502IBA 01/2015
1	isothiocyanic acidIBA 01/2015
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2015
1	Alkaline PhosphataseIBA 01/2015
1	Betulinic AcidIBA 01/2015
1	Integrin alpha1beta1IBA 01/2014
1	Dinoprostone (PGE2)FDA Link 01/2014
1	Naproxen (Naprosyn)FDA LinkGeneric 01/2014
1	ChemokinesIBA 12/2013
1	CollagenIBA 12/2013
1	AntibodiesIBA 12/2013
1	Pregnane X ReceptorIBA 12/2013
1	Proto-Oncogene Proteins c-metIBA 12/2013
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 12/2013
1	Interleukin-10 ReceptorsIBA 12/2013
1	Lymphotoxin-alpha (Lymphotoxin)IBA 12/2013
1	GlucocorticoidsIBA 11/2013
1	ChromatinIBA 11/2013
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2013
1	Methionine (L-Methionine)FDA Link 01/2013
1	Peptides (Polypeptides)IBA 01/2013
1	farnesoid X-activated receptorIBA 04/2012
1	SteroidsIBA 04/2012
1	gorgosterolIBA 04/2012
1	Viral ProteinsIBA 01/2012
1	SterolsIBA 01/2012
1	Fluorescein-5-isothiocyanate (FITC)IBA 01/2012
1	Leflunomide (Arava)FDA LinkGeneric 01/2012
1	Insulin (Novolin)FDA Link 01/2012
1	7-hydroxytheonellasterolIBA 01/2012
1	Dextrans (Dextran)FDA Link 01/2012
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2012

Therapy/Procedure

7	Therapeutics 03/2022 - 01/2012
2	Highly Active Antiretroviral Therapy (HAART) 01/2014 - 01/2012
1	Immunomodulation 10/2019
1	Intradermal Injections 01/2015
1	Ligation 01/2012